Speaker Profile
M.D., Professor, Yale
Biography
Kevan Herold, MD is Professor of Immunobiology and Internal Medicine at the Yale School of Medicine. His career has involved translational studies of the pathogenesis and treatment of immune diseases. He has been the PI of the clinical trials that led to the approval of teplizumab for treatment and prevention of Type 1 diabetes in addition to other immunologic and metabolic agents. His work has spanned a number of aspects of the pathogenesis of autoimmune diabetes including the immune mechanisms and the effects of autoimmunity on beta cells, with studies in preclinical and with clinical samples. His lab identified a subpopulation of beta cells that appear to resist immune attack. He developed an assay to measure β cell death in vivo and described changes in beta cells that occur in response to immunologic stressors which, he postulated may enable their survival
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
